The ACC.22 provides an engaging and interactive forum where attendees can learn about the latest science and innovation from top experts and colleagues, and get the latest practice-changing updates in cardiovascular care.
Look out for HealthCore’s latest cardiovascular research at ACC.22. Registration is required to view presentations. For more information, go to https://accscientificsession.acc.org/.
Session 1195 – Pulmonary Vascular Disease: Clinical and Population Science Digital Presentations
1195-002 / 2 | Real-World Perspective: Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Pulmonary Arterial Hypertension in the United States
Lia N. Pizzicato1, Vijay R. Nadipelli2, Samuel Governor1, Jianbin Mao2, Stephan Lanes1, John Butler2, Rebecca S. Pepe1, Hemant Phatak2, Karim El-Kersh3
1HealthCore Inc., Wilmington, DE, 2Acceleron Pharma Inc., a wholly owned subsidiary of Merck Sharp & Dohme Corp., Cambridge, MA, 3University of Nebraska Medical Center, Omaha, NE
Session 2004 – Spotlight on Special Topics: Cardio-oncology 13
2004-129 / 129 – Risk of Venous Thromboembolism in Patients on First Line of Therapy for Advanced Non-Small Cell Lung Cancer: A Comparison of Immune Checkpoint Inhibitors and Chemotherapy Regimens
Alok A. Khorana1, Lisa Rosenblatt2, Radhika Pisupati2, Chi Nguyen3, John Barron3, Kerrin Gallagher3, Jennell Palaia2, T. Christopher Bond2
1Cleveland Clinic, Cleveland, OH; 2Bristol Myers Squibb, New York, NY; 3HealthCore, Inc., Wilmington, DE
*HealthCore authors are indicated in bold.